Health & Medicine

Understanding what influences frailty opens the door to earlier screening and personalized approaches to supporting healthy aging, researchers say

Unapproved peptides that lack safety and efficacy data carry substantial risks and belong in a laboratory, not your body, Phillips warns.

The funding will accelerate the move toward human trials, enabling preclinical studies, regulatory preparation and early-phase clinical trial design.

Patients who had the procedure experienced a significantly better quality of life and less severe post-thrombotic syndrome, a painful condition that affects 20 to 50 per cent of people who had a deep vein thrombosis.

How complex sounds can improve healthcare, navigation and research into how we hear.

The first-of-its-kind study provides a credible estimate for a group that has been “statistically invisible” in policy and service planning.

The EMBOLDEN study with older adults and a project on local 2SLGBTQ+ histories were recognized at the Community-Engaged Research Awards. 

Denise Catacutan brought home the gold, and Jeremie Alexander the bronze in a highly competitive competition, underscoring McMaster's position as a global leader in next-generation antibiotic discovery.

New findings underscore the resilience of drug-resistant bacteria, and the need to carefully handle promising therapies like phages, which are the viruses that prey on them.

At Yale’s Microbial Sciences Institute, Colautti is leveraging new tools to answer ambitious, fundamental questions about the biology of these bugs.  

A new study finds that missing gut bacteria may prevent some people with celiac disease from fully benefiting from high-fibre supplements or diets.

A global team co-led by McMaster researchers found that fluvoxamine significantly improved fatigue and quality of life among adults with long COVID.